• Improving osteoarthritis trials: "We have to start by identifying biological markers for disease progression"

    30 May 2017

    Interview with Professor John Loughlin, Newcastle University

    An estimated 9.6% of men and 18% of women over the age of 60...

    Read more
  • Live from OARSI: two APPROACH members on the new Executive Committee of the Board of Directors

    28 April 2017

    Yesterday evening, Professor John Loughlin (right in picture), President of the Osteoarthritis Research Society International (...

    Read more
  • Exciting presentations by APPROACH members at OARSI World Congress

    24 April 2017

    This week, the Osteoarthritis Research Society International (OARSI) World Congress takes...

    Read more
  • APPROACH reseacher publishes high impact review on metabolism in osteoarthritis

    10 April 2017

    Recent research suggests that metabolic pathways play an important role in osteoarthritis (OA), and key metabolic pathways and mediators might be...

    Read more
  • OARSI Requests that FDA Consider Osteoarthritis as a Serious Disease

    06 December 2016

    The Osteoarthritis Research Society International (OARSI) submitted a white paper on December 1, 2016 asking the Federal Drug Administration (FDA...

    Read more
  • Successful Annual Meeting in Darmstadt

    29 November 2016

    Last week, the APPROACH Consortium met for its Annual Meeting. The meeting was organized at the Merck Darmstadt site, where about 45 project...

    Read more
  • Keynote lecture on APPROACH at the International Workshop on Osteoarthritis Imaging

    09 June 2016

    On 16 June 2016, Harrie Weinans (UMCU) will present a keynote lecture on the APPROACH project at the International Workshop on Osteoarthritis...

    Read more
  • Launch new website

    09 November 2015

    Welcome to our new website.


    Read more
  • Approach Project receives 15 million Euro research funding

    16 September 2015

    Pan-European APPROACH project receives 15 million Euro research funding to find the right osteoarthritis medicine for the right patient.

    Read more